23 Biotechnology Stocks Moving In Monday's After-Market Session

Gainers

Acceleron Pharma, Inc. XLRN stock moved upwards by 66.3% to $87.90 during Monday's after-market session. The most recent rating by Citigroup, on January 22, is at Buy, with a price target of $75.00.

Surface Oncology, Inc. SURF stock increased by 17.2% to $3.40.

Cleveland BioLabs, Inc. CBLI shares surged 14.9% to $4.71.

Inovio Pharmaceuticals, Inc. INO stock increased by 11.7% to $5.94. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.

Vaccinex, Inc. VCNX shares increased by 10.9% to $7.80.

Cocrystal Pharma, Inc. COCP shares rose 8.4% to $0.89.

Miragen Therapeutics, Inc. MGEN shares rose 7.5% to $1.57. The most recent rating by Baird, on December 12, is at Neutral, with a price target of $1.00.

BioCryst Pharmaceuticals, Inc. BCRX shares moved upwards by 7.5% to $3.45. According to the most recent rating by Bank of America, on November 15, the current rating is at Buy.

Moderna, Inc. MRNA shares increased by 6.6% to $24.25. The most recent rating by Bank of America, on December 03, is at Buy, with a price target of $29.00.

Kitov Pharma, Inc. KTOV stock rose 6.5% to $0.76.

Applied Genetic Tech, Inc. AGTC stock increased by 5.6% to $8.30.

Vir Biotechnology, Inc. VIR stock moved upwards by 5.3% to $26.10. The most recent rating by Baird, on November 14, is at Neutral, with a price target of $17.00.

NuCana, Inc. NCNA shares surged 5.3% to $5.56. The most recent rating by H.C. Wainwright, on November 15, is at Buy, with a price target of $17.00.

Pulmatrix, Inc. PULM shares surged 4.3% to $1.70.

GlycoMimetics, Inc. GLYC stock moved upwards by 4.0% to $4.45. The most recent rating by Roth Capital, on November 14, is at Buy, with a price target of $12.00.

Unum Therapeutics, Inc. UMRX shares surged 3.9% to $0.98. The most recent rating by Morgan Stanley, on November 27, is at Overweight, with a price target of $3.00.

Aevi Genomic Medicine, Inc. GNMX stock moved upwards by 3.5% to $0.19.

Therapix Biosciences, Inc. TRPX stock increased by 3.5% to $0.57.

CASI Pharmaceuticals, Inc. CASI stock moved upwards by 3.4% to $3.05.

 

Losers

Immunogen, Inc. IMGN shares fell 4.2% to $4.37 during Monday's after-market session.

ChemoCentryx, Inc. CCXI shares decreased by 4.0% to $39.00. The most recent rating by H.C. Wainwright, on January 24, is at Buy, with a price target of $60.00.

Syros Pharmaceuticals, Inc. SYRS stock fell 3.9% to $6.98. The most recent rating by Wedbush, on January 17, is at Neutral, with a price target of $9.00.

Tocagen, Inc. TOCA stock plummeted 3.6% to $0.52.

Posted In: After-Hours CenterMarketsMoversTrading IdeasBiotechnology Stocks After-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...